CD4 and Alzheimer disease: In addition, the PROGENy analysis revealed that the low-CR group showed significant upregulation in 11 out of 14 classic disease progression-related pathways (Figure 4F), suggesting that low levels of CRscore in CD4+ T cells seem to be more closely related to AD progression.